Home Global FT4 immunoassay standardization. Response to: Kratzsch J et al. Global FT4 immunoassay standardization: an expert opinion review
Article
Licensed
Unlicensed Requires Authentication

Global FT4 immunoassay standardization. Response to: Kratzsch J et al. Global FT4 immunoassay standardization: an expert opinion review

  • John E. Midgley EMAIL logo
Published/Copyright: February 19, 2021

Received: 2021-01-09
Accepted: 2021-02-11
Published Online: 2021-02-19
Published in Print: 2021-05-26

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. COVID-19: which lessons have we learned?
  4. Review
  5. Global FT4 immunoassay standardization: an expert opinion review
  6. Mini Review
  7. Mechanism of bilirubin elimination in urine: insights and prospects for neonatal jaundice
  8. Opinion Paper
  9. Laboratory medicine in the COVID-19 era: six lessons for the future
  10. EFLM Paper
  11. How to meet ISO15189:2012 pre-analytical requirements in clinical laboratories? A consensus document by the EFLM WG-PRE
  12. General Clinical Chemistry and Laboratory Medicine
  13. External quality assessment of M-protein diagnostics: a realistic impression of the accuracy and precision of M-protein quantification
  14. Error simulation modeling to assess the effects of bias and precision on bilirubin measurements used to screen for neonatal hyperbilirubinemia
  15. NT-proBNP levels in preeclampsia, intrauterine growth restriction as well as in the prediction on an imminent delivery
  16. Serum N-glycan fingerprint nomogram predicts liver fibrosis: a multicenter study
  17. Hematology and Coagulation
  18. Performance of digital morphology analyzer Vision Pro on white blood cell differentials
  19. Cardiovascular Diseases
  20. Prognostic implication of elevated cardiac troponin I in patients visiting emergency department without diagnosis of coronary artery disease
  21. Relationships between renal function variations and relative changes in cardiac troponin T concentrations based on quantile generalized additive models (qgam)
  22. Diabetes
  23. Association of hemoglobin H (HbH) disease with hemoglobin A1c and glycated albumin in diabetic and non-diabetic patients
  24. Comparative study of i-SENS glucometers in neonates using capillary blood samples
  25. Infectious Diseases
  26. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay
  27. Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients
  28. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study
  29. Letters to the Editors
  30. Global FT4 immunoassay standardization. Response to: Kratzsch J et al. Global FT4 immunoassay standardization: an expert opinion review
  31. Free-thyroxine standardization: waiting for Godot while well serving our patients today
  32. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria
  33. Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays
  34. Prevention and control of COVID-19 in the penitentiary of Florence
  35. Pooling for SARS-CoV-2-testing: comparison of three commercially available RT-qPCR kits in an experimental approach
  36. Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death
  37. Next-generation sequencing and RT-PCR to identify a 32-day SARS-CoV-2 carrier
  38. 25-Hydroxyvitamin D concentrations in COVID-19 patients hospitalized in intensive care unit during the first wave and the second wave of the pandemic
  39. Laboratory findings in a child with SARS-CoV-2 (COVID-19) multisystem inflammatory syndrome
  40. Discrepant cardiac troponin results in a young woman
  41. Response to: towards the rational utilization of SARS-CoV-2 serological tests in clinical practice
  42. Congress Abstract
  43. 12th National Scientific Congress SPML,29–31 October 2020, Online, Portugal
Downloaded on 3.7.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2021-0036/html
Scroll to top button